Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
1.820
+0.010 (0.55%)
At close: Sep 26, 2025, 4:00 PM EDT
1.840
+0.020 (1.09%)
After-hours: Sep 26, 2025, 7:59 PM EDT
Propanc Biopharma Employees
As of June 30, 2024, Propanc Biopharma had 2 total employees, including 1 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$27,605,209
Market Cap
23.23M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PPCB News
- 10 days ago - Propanc Biopharma Receives Certificate of Grant for “Proenzyme Composition” Patent from US Patent & Trademark Office - GlobeNewsWire
- 25 days ago - Propanc Biopharma Announces Plan to Acquire $100 Million of Ethereum - GlobeNewsWire
- 4 weeks ago - Propanc Biopharma Provides Shareholder Update - GlobeNewsWire
- 5 weeks ago - Propanc Biopharma Announces Closing of Public Offering and Uplisting to NASDAQ - GlobeNewsWire
- 6 weeks ago - U.S. IPO Weekly Recap: Bullish And Miami International Complete The Last Major IPOs Of The Summer - Seeking Alpha
- 6 weeks ago - Propanc Biopharma Announces Nasdaq Uplisting and Pricing of $4 Million Public Offering - GlobeNewsWire